108.28
price up icon0.06%   0.06
pre-market  Vorhandelsmarkt:  108.40   0.12   +0.11%
loading

Gilead Sciences Inc Aktie (GILD) Neueste Nachrichten

pulisher
07:49 AM

What drives Gilead Sciences Inc. stock priceBreakthrough investment results - jammulinksnews.com

07:49 AM
pulisher
Jul 21, 2025

After Gilead Deal, Hookipa Hangs Up Its Hat - insights.citeline.com

Jul 21, 2025
pulisher
Jul 21, 2025

Gilead Sciences (GILD) Reaches Deal to Offer HIV Vaccine to Low and Middle-Income Nations - MSN

Jul 21, 2025
pulisher
Jul 21, 2025

Hookipa, having sold off vaccines to Gilead, opts to wind down - Fierce Biotech

Jul 21, 2025
pulisher
Jul 20, 2025

Gilead Sciences Inc. Stock Analysis and ForecastMarket-leading growth rates - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 20, 2025

Gilead’s HIV Strength Drives Gains, But Pipeline Is Key - Finimize

Jul 20, 2025
pulisher
Jul 20, 2025

Why Gilead Sciences (GILD) Appeals to Income Investors in the Pharma Sector - MSN

Jul 20, 2025
pulisher
Jul 19, 2025

Is Gilead Sciences Inc. a good long term investmentFree Wealth Planning Blueprint - Jammu Links News

Jul 19, 2025
pulisher
Jul 19, 2025

Lobbying Update: $90,000 of GILEAD SCIENCES INC. lobbying was just disclosed - Quiver Quantitative

Jul 19, 2025
pulisher
Jul 18, 2025

What analysts say about Gilead Sciences Inc. stockRapid wealth multiplication - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 18, 2025

HOOKIPA Pharma Inc. Announces Intent to Voluntarily Delist from Nasdaq and Pursue Asset Sale with Gilead Sciences - Quiver Quantitative

Jul 18, 2025
pulisher
Jul 18, 2025

HOOKIPA Pharma Exits Nasdaq Market as Gilead Sciences Acquires Key Drug Programs - Stock Titan

Jul 18, 2025
pulisher
Jul 17, 2025

Foster City drugs giant Gilead to pay $202 million over alleged kickback scheme - SiliconValley.com

Jul 17, 2025
pulisher
Jul 17, 2025

Pennsylvania to receive $1.2M from Gilead over kickback scheme to promote HIV drugs - WPXI

Jul 17, 2025
pulisher
Jul 17, 2025

Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know - MSN

Jul 17, 2025
pulisher
Jul 17, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Sciences, Inc.GILD - PR Newswire

Jul 17, 2025
pulisher
Jul 16, 2025

Attorney General Ellison helps secure $200M from Gilead for paying illegal kickbacks - Red Lake Nation News

Jul 16, 2025
pulisher
Jul 16, 2025

Gilead Sciences Inc. Agrees to $202 Million Settlement Over Kickbacks, Illinois Leads Charge with Multi-State Coalition - Hoodline

Jul 16, 2025
pulisher
Jul 16, 2025

Gilead To Pay $202 Million In Nationwide Settlement Over Illegal HIV Drug Kickback Scheme - MyChesCo

Jul 16, 2025
pulisher
Jul 16, 2025

Gilead Sciences CFO Dickinson sells $277k in stock By Investing.com - Investing.com South Africa

Jul 16, 2025
pulisher
Jul 16, 2025

Gilead reaches $202M settlement over kickback scheme to promote HIV drug - Crain's New York Business

Jul 16, 2025
pulisher
Jul 16, 2025

Troy Griffin on Gilead’s mission at Chosen Few picnic - rollingout.com

Jul 16, 2025
pulisher
Jul 16, 2025

Why Merck Is A Better Dividend Stock Than Gilead Sciences (NYSE:MRK) - Seeking Alpha

Jul 16, 2025
pulisher
Jul 16, 2025

Nevada to receive over $440K from Gilead settlement over alleged illegal kickbacks - KTVN

Jul 16, 2025
pulisher
Jul 16, 2025

Gilead Sciences Advances in Triple-Negative Breast Cancer Treatment - TipRanks

Jul 16, 2025
pulisher
Jul 16, 2025

Minnesota and Iowa join $202M Gilead settlement over kickbacks - KIMT

Jul 16, 2025
pulisher
Jul 16, 2025

New York AG Letitia James Clinches Monumental $202M Victory Against Gilead Sciences Over HIV Med Kickbacks - Hoodline

Jul 16, 2025
pulisher
Jul 16, 2025

Attorney General Raoul Announces More Than $200 Million Settlement With Gilead Sciences Over Illegal Kickbacks To Providers For Prescriptions - RiverBender.com

Jul 16, 2025
pulisher
Jul 16, 2025

Pennsylvania to Receive Over $1.2 Million in HIV Drug Kickback Settlement with Gilead - Franklin County Free Press

Jul 16, 2025
pulisher
Jul 16, 2025

AG Sunday Part of National Coalition Securing $200M+ from Gilead Sciences for Illegal Kickback Scheme to Sell HIV Drugs - exploreJefferson

Jul 16, 2025
pulisher
Jul 16, 2025

GILD Investors Have Opportunity to Join Gilead Sciences, Inc. Fraud Investigation with the Schall Law Firm - PR Newswire

Jul 16, 2025
pulisher
Jul 16, 2025

Gilead’s Vítor Papão on key partnerships and the role of tech in public health - Gulf Business

Jul 16, 2025
pulisher
Jul 15, 2025

Attorney General Bonta Helps Secure Over $200 Million from Gilead Sciences for Paying Illegal KickbacksState of California - State of California - Department of Justice (.gov)

Jul 15, 2025
pulisher
Jul 15, 2025

Here's Why Gilead Sciences (GILD) Fell More Than Broader Market - Yahoo Finance

Jul 15, 2025
pulisher
Jul 15, 2025

Tamar Braxton partners with Gilead for HIV awareness - Rolling Out

Jul 15, 2025
pulisher
Jul 15, 2025

Sector Update: Health Care - MarketScreener

Jul 15, 2025
pulisher
Jul 15, 2025

Pennsylvania to receive $1.28 million in settlement over Gilead’s illegal HIV drug kickback scheme - WTAJ

Jul 15, 2025
pulisher
Jul 15, 2025

Tamar Braxton & Gilead Partner For PrEP Promo To Black Women - Black America Web

Jul 15, 2025
pulisher
Jul 15, 2025

Gilead Sciences Reaches $202 Million Settlement Over Kickback Scheme Promoting HIV Drugs - MarketScreener

Jul 15, 2025
pulisher
Jul 15, 2025

Pennsylvania Part of National Coalition Securing $200M+ from Gilead Sciences for Illegal Kickback Scheme to Sell HIV Drugs - pennwatch.org

Jul 15, 2025
pulisher
Jul 15, 2025

Pennsylvania expected to get $1.28 million from biopharma company for violating anti-kickback laws - ABC27

Jul 15, 2025
pulisher
Jul 15, 2025

Massachusetts Secures $1.6 Million from Gilead in $202 Million Multi-State Settlement Over HIV Drug Kickbacks - Hoodline

Jul 15, 2025
pulisher
Jul 15, 2025

Gilead reaches $202M settlement over HIV drug speaker program - Seeking Alpha

Jul 15, 2025
pulisher
Jul 15, 2025

Tamar Braxton Partners with Gilead to Empower Black Women on HIV Prevention - ThisisRnB.com

Jul 15, 2025
pulisher
Jul 15, 2025

Bernstein Maintains Buy Rating on Gilead Sciences (GILD) Stock - Insider Monkey

Jul 15, 2025
pulisher
Jul 15, 2025

Gilead Beats Defamation Suit by Worker Accused of Sex Harassment - Bloomberg Law News

Jul 15, 2025
pulisher
Jul 15, 2025

Fighting Disease Requires More Than Just the Right Drug: Gilead - Mexico Business News

Jul 15, 2025
pulisher
Jul 15, 2025

Gilead, GSK/ViiV, Merck Present New HIV PrEP Frontiers at IAS25 - BioSpace

Jul 15, 2025
pulisher
Jul 15, 2025

Attorney General Schwalb Recovers Over $300,000 from Gilead Sciences for Illegal Kickback Scheme - District of Columbia | Attorney General (.gov)

Jul 15, 2025
pulisher
Jul 15, 2025

How the Inhaled Antibiotics Market Will Evolve by 2032Growth, - openPR.com

Jul 15, 2025
pulisher
Jul 15, 2025

Gilead's twice-yearly HIV PrEP set for wider rollout - pharmaphorum

Jul 15, 2025
pulisher
Jul 15, 2025

Gilead’s twice-yearly HIV prevention shot effective across diverse groups By Investing.com - Investing.com Nigeria

Jul 15, 2025
pulisher
Jul 15, 2025

Q1 Earnings Roundup: Gilead Sciences (NASDAQ:GILD) And The Rest Of The Therapeutics Segment - Yahoo Finance

Jul 15, 2025
drug_manufacturers_general PFE
$24.26
price down icon 0.86%
drug_manufacturers_general SNY
$47.93
price down icon 0.81%
$295.87
price up icon 0.38%
drug_manufacturers_general MRK
$79.31
price down icon 0.81%
drug_manufacturers_general NVO
$64.92
price up icon 0.95%
Kapitalisierung:     |  Volumen (24h):